Xu Linan, Wei Fengfang, Feng Jiayan, Liu Jiaojiao, Liu Jialu, Tang Xiaoshan, Fang Xiaoyan, Chen Jing, Zhai Yihui, Liu Haimei, Sun Li, Qian Yanyan, Wu Bingbing, Wang Huijun, Shen Qian, Rao Jia, Xu Hong
Department of Nephrology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Shanghai Kidney Development and Pediatric Kidney Disease Research Center, Shanghai, China.
Transl Pediatr. 2021 Nov;10(11):2985-2996. doi: 10.21037/tp-21-286.
Membranoproliferative glomerulonephritis (MPGN) is a rare histopathologic pattern of glomerular injury with limited studies in pediatric patients. Characteristics and outcomes of children with MPGN have also remained to be further explored.
We retrospectively reviewed the clinicopathological features, genetic findings, treatments and outcomes in 17 pediatric patients pathologically diagnosed with MPGN from 2007 to 2020 in the Children's National Medical Center in China.
Median age at disease onset was 9.9 years (IQR, 5.6-11.9 years). Most of the patients (12/17) had nephrotic range of proteinuria, and nephritic-nephrotic syndrome was the most common clinical presentation (35.2%). Secondary causes were identified in eight patients including hepatitis B virus (HBV) infection (n=4), methylmalonic acidemia (MMA, n=2), rheumatoid arthritis (RA, n=1) and Aymé-Gripp Syndrome (n=1). The nine patients with primary MPGN were further identified as immune-complex mediated MPGN (n=8), and unclassifiable MPGN (U-MGPN, n=1). Genetic analyses identified pathogenic variants of gene in two cases of MMA and established the diagnosis for Aymé-Gripp syndrome in one case with a variant of gene. Comparing study between the complete or partial remission group (n=8) and non-response group (n=9) showed a significant difference in the timing of renal biopsy (P<0.05). Normal renal function was preserved in ten patients at the last follow-up. Two patients developed into end-stage renal disease (ESRD).
Children with MPGN pattern present heterogenous clinical features. Genetic detection helps to explore underlying causes of MPGN. Early identification of the primary or secondary causes of MPGN in children is vital.
膜增生性肾小球肾炎(MPGN)是一种罕见的肾小球损伤组织病理学类型,关于儿科患者的研究有限。MPGN患儿的特征和预后仍有待进一步探索。
我们回顾性分析了2007年至2020年在中国国家儿童医学中心病理诊断为MPGN的17例儿科患者的临床病理特征、基因检测结果、治疗方法及预后。
发病时的中位年龄为9.9岁(四分位间距,5.6 - 11.9岁)。大多数患者(12/17)有肾病范围的蛋白尿,肾炎 - 肾病综合征是最常见的临床表现(35.2%)。在8例患者中发现了继发原因,包括乙型肝炎病毒(HBV)感染(n = 4)、甲基丙二酸血症(MMA,n = 2)、类风湿关节炎(RA,n = 1)和艾梅 - 格里普综合征(n = 1)。9例原发性MPGN患者进一步被鉴定为免疫复合物介导的MPGN(n = 8)和无法分类的MPGN(U - MGPN,n = 1)。基因分析在2例MMA患者中鉴定出致病基因变异,并在1例有基因变异的患者中确诊为艾梅 - 格里普综合征。完全或部分缓解组(n = 8)与无反应组(n = 9)的比较研究显示肾活检时间有显著差异(P < 0.05)。在最后一次随访时,10例患者肾功能正常。2例患者发展为终末期肾病(ESRD)。
MPGN型患儿表现出异质性临床特征。基因检测有助于探索MPGN的潜在病因。早期识别儿童MPGN的原发或继发原因至关重要。